Lecture 10: Antipsychotic drugs Flashcards
2 positive symptoms of schizophrenia
hallucinations
disorganized speech
2 negative symptoms of schizophrenia
anhedonia
flattened affect - lack of emotion or expression of emotion
3 cognitive symptoms of schizophrenia
decrease IQ
lack of attention
working memory impairments
Chlorpromazine and haloperidol
D2 dopamine receptor antagonist
direct correlation between clinical potency and D2 receptor affinity
cause serious motor impairments due to D2R antagonism
cause anhedonia and sedation
have anti-emetic properties
2 cause of schizophrenia
- too much dopamine
- GPCR signalling, Beta arrestin pathway inhibit
Evidence that schizophrenia is caused by excess dopamine
amphetamine induce psychosis in patients as it pumps dopamine from the presynaptic terminal into the synpase
schizophrenia patients release more dopamine in basal ganglia when given amphetamine
Evidence that schizophrenia is not only dependent on too much dopamine
amphetamine does not induce negative or cognitive symptoms
rather dysregulated than too much
Extrapyramidal side effects (EPS)
immobility and muscle rigidity
can be overcome with the addition of muscarinic antagonist
Tardive dyskinesia
occurs after long term treatment of antipsychotics
involuntary twitches of facial muscles
dopamine hypersensitivity
Hyperprolactinemia by APS
antagonism of dopamine lead to less more secretion of prolactin
cause more producing of milk and suppression of GnRH
disruption of menstrual cycle and erectile dysfunction in male
Clozapine, Risperidone, Olanzapine, Quetiapine, Ziprasidone, Aripiprazole
atypical APS
better tolerated
equal or greater affinity for 5HTw receptors than D2 receptor
antagonist at both
causes weight gain, increase cholesterol, diabetes
One important adverse effect for clozapine
agranulocytosis
Aripiprazole
partial agonist at the D2 receptor (instead of competitive antagonist)
In cortex and hippocampus, partial agonist with activate D2R
In striatum, partial agonist will decrease D2R transmission
Aripiprazole MOA
In cortex not enough DA: partial agonist can bind more receptor to increase dopamine effect
In striatum too much DA: competes with DA so avoid full activation of dopamine as a full agonist (antagonizing effect)